F Bonfiglio1, P G Hysi2, W Ek1,3, V Karhunen4,5, N V Rivera1, M Männikkö4, H Nordenstedt6, M Zucchelli1, F Bresso1,7, F Williams8, H Tornblom9, P K Magnusson10, N L Pedersen10, J Ronkainen11,12, P T Schmidt7, M D'Amato1,13. 1. Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden. 2. Department of Ophthalmology, King's College London, St Thomas' Hospital Campus, London, UK. 3. Department of Immunology, Genetics and Pathology, Science for Life Laboratory Uppsala, Uppsala University, Uppsala, Sweden. 4. Center for Life Course Health Research, University of Oulu, Oulu, Finland. 5. Oulu University Hospital, Oulu, Finland. 6. Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden. 7. Department of Medicine Solna, Karolinska Institutet, Center for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden. 8. Department of Twin Research & Genetic Epidemiology, King's College London, London, UK. 9. Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 10. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. 11. Primary Health Care Centre, Tornio, Finland. 12. Center for Family Medicine, Karolinska Institutet, Stockholm, Sweden. 13. BioCruces Health Research Institute and Ikerbasque, Basque Foundation for Science, Bilbao, Spain.
Abstract
BACKGROUND: Gastroesophageal reflux disease (GERD), the regurgitation of gastric acids often accompanied by heartburn, affects up to 20% of the general population. Genetic predisposition is suspected from twin and family studies but gene-hunting efforts have so far been scarce and no conclusive genome-wide study has been reported. We exploited data available from general population samples, and studied self-reported reflux symptoms in relation to genome-wide single nucleotide polymorphism (SNP) genotypes. METHODS: We performed a GWAS meta-analysis of three independent population-based cohorts from Sweden, Finland, and UK. GERD cases (n=2247) and asymptomatic controls (n=4503) were identified using questionnaire-derived symptom data. Upon stringent quality controls, genotype data for more than 2.5M markers were used for association testing. Bioinformatic characterization of genomic regions associated with GERD included gene-set enrichment analysis (GSEA), in silico prediction of genetic risk effects on gene expression, and computational analysis of drug-induced gene expression signatures using Connectivity Map (cMap). KEY RESULTS: We identified 30 GERD suggestive risk loci (P≤5×10-5 ), with concordant risk effects in all cohorts, and predicted functional effects on gene expression in relevant tissues. GSEA revealed involvement of GERD risk genes in biological processes associated with the regulation of ion channel and cell adhesion. From cMap analysis, omeprazole had significant effects on GERD risk gene expression, while antituberculosis and anti-inflammatory drugs scored highest among the repurposed compounds. CONCLUSIONS: We report a large-scale genetic study of GERD, and highlight genes and pathways that contribute to further our understanding of its pathogenesis and therapeutic opportunities.
BACKGROUND:Gastroesophageal reflux disease (GERD), the regurgitation of gastric acids often accompanied by heartburn, affects up to 20% of the general population. Genetic predisposition is suspected from twin and family studies but gene-hunting efforts have so far been scarce and no conclusive genome-wide study has been reported. We exploited data available from general population samples, and studied self-reported reflux symptoms in relation to genome-wide single nucleotide polymorphism (SNP) genotypes. METHODS: We performed a GWAS meta-analysis of three independent population-based cohorts from Sweden, Finland, and UK. GERD cases (n=2247) and asymptomatic controls (n=4503) were identified using questionnaire-derived symptom data. Upon stringent quality controls, genotype data for more than 2.5M markers were used for association testing. Bioinformatic characterization of genomic regions associated with GERD included gene-set enrichment analysis (GSEA), in silico prediction of genetic risk effects on gene expression, and computational analysis of drug-induced gene expression signatures using Connectivity Map (cMap). KEY RESULTS: We identified 30 GERD suggestive risk loci (P≤5×10-5 ), with concordant risk effects in all cohorts, and predicted functional effects on gene expression in relevant tissues. GSEA revealed involvement of GERD risk genes in biological processes associated with the regulation of ion channel and cell adhesion. From cMap analysis, omeprazole had significant effects on GERD risk gene expression, while antituberculosis and anti-inflammatory drugs scored highest among the repurposed compounds. CONCLUSIONS: We report a large-scale genetic study of GERD, and highlight genes and pathways that contribute to further our understanding of its pathogenesis and therapeutic opportunities.
Authors: Alexandra Argyrou; Evangelia Legaki; Christos Koutserimpas; Maria Gazouli; Ioannis Papaconstantinou; George Gkiokas; George Karamanolis Journal: J Neurogastroenterol Motil Date: 2019-07-01 Impact factor: 4.924
Authors: Alexandra Argyrou; Evangelia Legaki; Christos Koutserimpas; Maria Gazouli; Ioannis Papaconstantinou; George Gkiokas; George Karamanolis Journal: World J Clin Cases Date: 2018-08-16 Impact factor: 1.337
Authors: Mohamed Magdi Atta; Mohamed Hisham Sayed; Mohamed A Zayed; Sultan A Alsulami; Ahmed T Al-Maghrabi; Abdulhfeez Y Kelantan Journal: Int J Gen Med Date: 2019-08-19
Authors: Jiyuan An; Puya Gharahkhani; Matthew H Law; Jue-Sheng Ong; Xikun Han; Catherine M Olsen; Rachel E Neale; John Lai; Tom L Vaughan; Ines Gockel; René Thieme; Anne C Böhmer; Janusz Jankowski; Rebecca C Fitzgerald; Johannes Schumacher; Claire Palles; David C Whiteman; Stuart MacGregor Journal: Nat Commun Date: 2019-09-16 Impact factor: 14.919
Authors: Jue-Sheng Ong; Jiyuan An; Xikun Han; Matthew H Law; Priyanka Nandakumar; Johannes Schumacher; Ines Gockel; Anne Bohmer; Janusz Jankowski; Claire Palles; Catherine M Olsen; Rachel E Neale; Rebecca Fitzgerald; Aaron P Thrift; Thomas L Vaughan; Matthew F Buas; David A Hinds; Puya Gharahkhani; Bradley J Kendall; Stuart MacGregor Journal: Gut Date: 2021-06-29 Impact factor: 31.793